Dociparstat for the Treatment of Severe COVID-19 in Adults at High Risk of Respiratory Failure
Public ClinicalTrials.gov record NCT04389840. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2/3 Study to Evaluate the Safety and Efficacy of Dociparstat Sodium for the Treatment of Severe COVID-19 in Adults at High Risk of Respiratory Failure
Study identification
- NCT ID
- NCT04389840
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 2, Phase 3
- Lead sponsor
- Jazz Pharmaceuticals
- Industry
- Enrollment
- 27 participants
Conditions and interventions
Conditions
Interventions
- Dociparstat sodium Drug
- Placebo Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years to 85 Years
- Sex
- All
- Healthy volunteers
- Not listed
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jul 7, 2020
- Primary completion
- May 19, 2021
- Completion
- May 19, 2021
- Last update posted
- Aug 29, 2022
2020 – 2021
United States locations
- U.S. sites
- 12
- U.S. states
- 8
- U.S. cities
- 11
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| University of Alabama at Birmingham | Birmingham | Alabama | 35294 | — |
| Advanced Pulmonary Research Institute/Wellington Regional Medical Center | Loxahatchee Groves | Florida | 33470 | — |
| Augusta University | Augusta | Georgia | 30912 | — |
| Our Lady of the Lake | Baton Rouge | Louisiana | 70808 | — |
| Tulane University | New Orleans | Louisiana | 70112 | — |
| University Medical Center | New Orleans | Louisiana | 70112 | — |
| William Beaumont Hospital | Royal Oak | Michigan | 48073 | — |
| Ascension Macomb-Oakland Cardiovascular Research | Warren | Michigan | 48072 | — |
| Wake Forest Baptist Health | Winston-Salem | North Carolina | 27157 | — |
| Texas Health Harris Methodist Hospital Fort Worth | Dallas | Texas | 76104 | — |
| Ascension St. Francis Hospital | Milwaukee | Wisconsin | 53215 | — |
| Ascension All Saints Hospital | Racine | Wisconsin | 53405 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04389840, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 29, 2022 · Synced Apr 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT04389840 live on ClinicalTrials.gov.